Examples of 'receiving placebo' in a sentence
Meaning of "receiving placebo"
Refers to the act of receiving a fake treatment or substance, typically used in medical studies or experiments for comparison purposes
How to use "receiving placebo" in a sentence
Basic
Advanced
receiving placebo
Volunteers receiving placebo experienced five AEs.
Similar effects occurred in patients receiving placebo.
One participant receiving placebo showed an episode of thrombosis.
Uric acid levels were elevated in subjects receiving placebo.
One patient receiving placebo died for reasons unrelated to the study drug.
Weeks for those receiving placebo.
Each of these same findings was reported at a similar frequency in patients receiving placebo.
Plasma vWF concentration in the subjects receiving placebo does not change significantly during the study.
None of these improvements were observed in the group receiving placebo.
At that time, patients receiving placebo were offered to switch over to sunitinib.
This compared with around a quarter of the patients receiving placebo.
None of the patients receiving placebo had these problems, the researchers said.
Patients receiving basiliximab show an amelioration of the symptoms as compared to patients receiving placebo.
It may surprise many people to know that patients receiving placebo therapies routinely exhibit improvement.
Patients receiving montelukast had more days without asthma than those receiving placebo.
See also
Patients receiving placebo who experienced disease progression were offered open-label regorafenib cross-over option.
Patients receiving cannabinoids had improved immune function compared with those receiving placebo.
In comparison, patients receiving placebo rTMS as a whole only experienced a 7 % reduction.
The outcomes of those who continued to receive antipsychotics were compared with those receiving placebo.
Serious side effects were more common among participants receiving placebo than in those given candesartan . [ 4 ].
These values were not statistically different from that observed reduction in patients receiving placebo.
Patients receiving placebo were switched to Simponi 50 mg after week 24.
The patients receiving evening primrose oil improved to a greater extent than those receiving placebo.
None of the 116 patients receiving placebo had a SVR.
The primary objective was to compare PFS in patients receiving sunitinib versus patients receiving placebo.
Patients receiving Cimzia and 1,137 patients receiving placebo during the controlled period.
More adult patients receiving Remicade had a reduction in symptoms than those receiving placebo.
In the study, 37 percent of patients receiving placebo plus pegylated interferon and ribavirin achieved SVR12.
No increase in CSF IgG was observed in subjects receiving placebo.
Safety and tolerability were similar in patients receiving placebo and those receiving RTX.
Guanfacine showed a significantly greater improvement in the ADHD-RS-IV total score compared with subjects receiving placebo.
Animals were subsequently allocated to one of seven groups ( n=12 ), receiving placebo or treatment as follows,.
In addition, fewer of the patients receiving Xolair had exacerbations than those receiving placebo.
Fatal gastrointestinal bleeding occurred in 0.98 % of patients receiving placebo in the GIST phase 3 study.
In comparison, the treatments were only interrupted in 12 and 31 % of cases receiving placebo.
Fatal gastrointestinal bleeding was reported in 0.98 % of patients receiving placebo in the GIST Phase 3 study.
Eleven of 29 participants receiving methadone achieved 30 % pain relief versus seven of 29 receiving placebo.
This compared with 33 % of the patients receiving placebo.
Midazolam treatment was not required in 53 % of patients receiving Dexdor compared with 14 % receiving placebo.
Little to no increase in CSF IgG was observed in subjects receiving placebo.
A deterioration in dyspnea was reported only by 1 patient receiving placebo.
Patients receiving pregabalin and 7 % for patients receiving placebo.
One ILD-type event was fatal, and this occurred in a patient receiving placebo.
Over 4 years, mean AUA scores fell by 5 points among men receiving placebo.
More patients receiving ADLYXINE ( 4.3 % ) discontinued treatment due to gastrointestinal adverse reactions than patients receiving placebo 0.5.
You'll also be interested in:
Examples of using Placebo
Show more
The placebo that was used included lactose
Endocannabinoids are involved in placebo induced analgesia responses
Placebo was not effective in any of the patients
Examples of using Receiving
Show more
The child is not receiving enough medicine
Receiving and inspection activities in field missions
There is also a light receiving section at the
